MEZZALANA, ENRICA
MEZZALANA, ENRICA
DIPARTIMENTO DI INGEGNERIA INDUSTRIALE E DELL'INFORMAZIONE
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab.
2013-01-01 Mezzalana, Enrica; A., Macdonald; DE NICOLAO, Giuseppe; S., Zamuner
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases.
2012-01-01 Mezzalana, Enrica; A., Macdonald; R., Bizzotto; DE NICOLAO, Giuseppe; S., Zamuner
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement
2014-01-01 Mezzalana, Enrica; K., Page; A., van Maurik; A., Mcdonald; DE NICOLAO, Giuseppe; S., Zamuner
Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter
2015-01-01 Larizza, Cristiana; Pasotti, Lorenzo; Mezzalana, Enrica; Borella, Elisa; Smith, G.; Magni, Paolo
Evaluation of software tools for Bayesian estimation on population models with count and continuous data
2015-01-01 Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Mezzalana, Enrica; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues
2018-01-01 Lavezzi, S. M.; Mezzalana, E.; Zamuner, S.; De Nicolao, G.; Ma, P.; Simeoni, M.
Multinomial Logistic Functions in Markov Chain Models of Sleep Architecture: Internal and External Validation and Covariate Analysis
2011-01-01 Bizzotto, Roberto; Zamuner, Stefano; Mezzalana, Enrica; DE NICOLAO, Giuseppe; Gomeni, Roberto; Hooker Andrew, C.; Karlsson Mats, O.
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
2015-01-01 Swat, Mj; Moodie, S; Wimalaratne, Sm; Kristensen, Nr; Lavielle, M; Mari, A; Magni, Paolo; Smith, Mk; Bizzotto, R; Pasotti, Lorenzo; Mezzalana, Enrica; Comets, E; Sarr, C; Terranova, N; Blaudez, E; Chan, P; Chard, J; Chatel, K; Chenel, M; Edwards, D; Franklin, C; Giorgino, T; Glont, M; Girard, P; Grenon, P; Harling, K; Hooker, Ac; Kaye, R; Keizer, R; Kloft, C; Kok, Jn; Kokash, N; Laibe, C; Laveille, C; Lestini, Giulia; Mentre, F; Munafo, A; Nordgren, R; Nyberg, Hb; Parra Guillen, Zp; Plan, E; Ribba, B; Smith, G; Troconiz, If; Yvon, F; Milligan, Pa; Harnisch, L; Karlsson, M; Hermjakob, H; Le Novere, N.
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture
2015-01-01 Page, Kevin R; Mezzalana, Enrica; Macdonald, Alexander J.; Zamuner, Stefano; DE NICOLAO, Giuseppe; Van Maurik, Andre
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. | 1-gen-2013 | Mezzalana, Enrica; A., Macdonald; DE NICOLAO, Giuseppe; S., Zamuner | |
| A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. | 1-gen-2012 | Mezzalana, Enrica; A., Macdonald; R., Bizzotto; DE NICOLAO, Giuseppe; S., Zamuner | |
| A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement | 1-gen-2014 | Mezzalana, Enrica; K., Page; A., van Maurik; A., Mcdonald; DE NICOLAO, Giuseppe; S., Zamuner | |
| Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter | 1-gen-2015 | Larizza, Cristiana; Pasotti, Lorenzo; Mezzalana, Enrica; Borella, Elisa; Smith, G.; Magni, Paolo | |
| Evaluation of software tools for Bayesian estimation on population models with count and continuous data | 1-gen-2015 | Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Mezzalana, Enrica; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo | |
| MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues | 1-gen-2018 | Lavezzi, S. M.; Mezzalana, E.; Zamuner, S.; De Nicolao, G.; Ma, P.; Simeoni, M. | |
| Multinomial Logistic Functions in Markov Chain Models of Sleep Architecture: Internal and External Validation and Covariate Analysis | 1-gen-2011 | Bizzotto, Roberto; Zamuner, Stefano; Mezzalana, Enrica; DE NICOLAO, Giuseppe; Gomeni, Roberto; Hooker Andrew, C.; Karlsson Mats, O. | |
| Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development | 1-gen-2015 | Swat, Mj; Moodie, S; Wimalaratne, Sm; Kristensen, Nr; Lavielle, M; Mari, A; Magni, Paolo; Smith, Mk; Bizzotto, R; Pasotti, Lorenzo; Mezzalana, Enrica; Comets, E; Sarr, C; Terranova, N; Blaudez, E; Chan, P; Chard, J; Chatel, K; Chenel, M; Edwards, D; Franklin, C; Giorgino, T; Glont, M; Girard, P; Grenon, P; Harling, K; Hooker, Ac; Kaye, R; Keizer, R; Kloft, C; Kok, Jn; Kokash, N; Laibe, C; Laveille, C; Lestini, Giulia; Mentre, F; Munafo, A; Nordgren, R; Nyberg, Hb; Parra Guillen, Zp; Plan, E; Ribba, B; Smith, G; Troconiz, If; Yvon, F; Milligan, Pa; Harnisch, L; Karlsson, M; Hermjakob, H; Le Novere, N. | |
| Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture | 1-gen-2015 | Page, Kevin R; Mezzalana, Enrica; Macdonald, Alexander J.; Zamuner, Stefano; DE NICOLAO, Giuseppe; Van Maurik, Andre |